FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...

About Legacy Foot & Ankle Legacy Foot & Ankle is a podiatry practice focused on comprehensive foot and ankle care. Under the ...

WhiteSands Alcohol & Drug Rehab Tampa has published a new educational resource exploring the physiological effects of alcohol ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation – a ...

Turmeric has long been celebrated as the golden child of anti-inflammatory spices, but it's not the only powerhouse in your ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer.

A form of very low-calorie fasting-mimicking diet may help alleviate symptoms of mild-to-moderate Crohn's disease.

Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, ...

Title: Gemini restores normal innate immune response in CKD patients Presenter: Robin Marsden, Senior Vice President of Biology, Revelation Biosciences Date/Time: Sunday, March 29, 2026 5:30 p.m.